Vanguard Group
BDR

Vanguard Group’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Vanguard Group’s Portfolio BDR Stock Details BDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-81,448
Closed -$52K – 4652
2022
Q1 		$52K Hold
81,448
– – ﹤0.01% 4618
2021
Q4 		$48K Hold
81,448
– – ﹤0.01% 4627
2021
Q3 		$93K Buy
81,448
+65,048
+397% +$80.1K ﹤0.01% 4532
2021
Q2 		$22K Hold
16,400
– – ﹤0.01% 4422
2021
Q1 		$24K Hold
16,400
– – ﹤0.01% 4332
2020
Q4 		$22K Hold
16,400
– – ﹤0.01% 4199
2020
Q3 		$13K Hold
16,400
– – ﹤0.01% 4104
2020
Q2 		$12K Hold
16,400
– – ﹤0.01% 4069
2020
Q1 		$10K Hold
16,400
– – ﹤0.01% 4069
2019
Q4 		$12K Hold
16,400
– – ﹤0.01% 4113
2019
Q3 		$11K Hold
16,400
– – ﹤0.01% 4145
2019
Q2 		$16K Hold
16,400
– – ﹤0.01% 4156
2019
Q1 		$18K Hold
16,400
– – ﹤0.01% 4101
2018
Q4 		$18K Hold
16,400
– – ﹤0.01% 4125
2018
Q3 		$20K Hold
16,400
– – ﹤0.01% 4153
2018
Q2 		$19K Buy
+16,400
New +$17.5K ﹤0.01% 4123

Vanguard Group's BDR Position: Q2 2022 in Review

Vanguard Group sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2022, closing a stake of 81,448 shares — an estimated $52K sold.

Vanguard Group first reported a position in BDR in Q2 2018 and held it in 16 quarters. The position peaked at $93K in Q3 2021. 0 funds tracked by Wall St. Rank hold BDR as of Q2 2022.

  • Vanguard Group reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2022 after selling out during the quarter.
  • Vanguard Group sold 81,448 Blonder Tongue Laboratories Inc shares in Q2 2022, an estimated $52K.
  • Vanguard Group first reported a position in Blonder Tongue Laboratories Inc in Q2 2018 and held it in 16 quarters.
  • Vanguard Group's Blonder Tongue Laboratories Inc position peaked at $93K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2022.

Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.